Edition:
United States

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

18.94USD
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
$18.94
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,735
52-wk High
$21.71
52-wk Low
$5.70

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.396
Sep '17 0.00 -0.539
Jun '17 0.00 -0.917
Mar '17 0.00 -1.262
FY 2016 Dec '16 0.00 -0.269
Sep '16 0.00 -3.026
Jun '16 0.73 -3.115
Mar '16 0.73 -3.204
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 18.57 46.82 4.69 --
Earnings (per share)
Quarter Ending Jun-18 3 -0.74 -0.66 -0.83 --
Quarter Ending Sep-18 3 -0.83 -0.70 -0.99 --
Year Ending Dec-18 3 -3.22 -2.83 -3.72 --
Year Ending Dec-19 4 -2.19 -1.10 -2.81 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.16 33.25
P/E High - Last 5 Yrs. -- 283.72 45.98
P/E Low - Last 5 Yrs. -- 95.28 24.86
Beta 2.32 0.75 0.80
Price to Sales (TTM) -- 137.70 7.20
Price to Book (MRQ) 6.36 19.28 5.06
Price to Tangible Book (MRQ) 9.81 24.18 6.69
Price to Cash Flow (TTM) -- 120.88 25.20
% Owned Institutions 40.35 11.42 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.76
Dividend 5 Year Growth Rate -- 1.94 3.96
Payout Ratio(TTM) -- 9.17 20.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 81.55 8.73
Sales (TTM) vs TTM 1 Yr. Ago -- 97.79 11.30
Sales - 5 Yr. Growth Rate -- 33.72 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -47.15 -66.22 22.52
EPS (TTM) vs TTM 1 Yr. Ago 74.42 -- --
EPS - 5 Yr. Growth Rate -- 47.04 10.26
Capital Spending - 5 Yr. Growth Rate -35.21 45.24 10.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.53
Current Ratio (MRQ) 8.13 6.01 3.61
LT Debt to Equity (MRQ) 0.00 23.49 11.52
Total Debt to Equity (MRQ) 0.00 25.92 14.21
Interest Coverage (TTM) -- -189.88 30.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 34.63 54.09
Gross Margin - 5 Yr. Avg. -- 55.35 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,151.11 -153.57 15.86
Operating Margin (TTM) -- -573.06 3.97
Operating Margin - 5 Yr. Avg. -1,221.86 -165.53 11.17
Pre-Tax Margin (TTM) -- -545.71 4.62
Pre-Tax Margin - 5 Yr. Avg. -1,268.38 -172.26 11.49
Net Profit Margin (TTM) -- -534.59 1.24
Net Profit Margin - 5 Yr. Avg. -1,268.38 -172.04 7.83
Effective Tax Rate (TTM) -- -0.67 31.24
Effective Tax Rate - 5 Yr. Avg. -- 18.14 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,627,894 806,826,037
Net Income/Employee (TTM) -2,365,740 954,925 94,789,739
Receivable Turnover (TTM) -- 6.54 5.54
Inventory Turnover (TTM) -- 2.39 3.44
Asset Turnover (TTM) 0.00 0.40 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -104.59 -0.73 10.47
Return on Assets - 5 Yr. Avg. -93.00 0.66 11.49
Return on Investment (TTM) -116.89 -0.71 13.13
Return on Investment - 5 Yr. Avg. -115.50 4.08 14.88
Return on Equity (TTM) -233.64 -2.76 14.96
Return on Equity - 5 Yr. Avg. -161.33 -0.32 16.18
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 30.77 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Acer Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.35%
# of Holders: 23
Total Shares Held: 3,025,047
3 Mo. Net Change: 21,662
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.